|
1
|
Falchook GS, Lewis KD, Infante JR, et al:
Activity of the oral MEK inhibitor trametinib in patients with
advanced melanoma: a phase 1 dose-escalation trial. Lancet Oncol.
13:782–789. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lavoie JN, L’Allemain G, Brunet A, Muller
R and Pouyssegur J: Cyclin D1 expression is regulated positively by
the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol
Chem. 271:20608–20616. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Weber JD, Raben DM, Phillips PJ and
Baldassare JJ: Sustained activation of
extracellular-signal-regulated kinase 1 (ERK1) is required for the
continued expression of cyclin D1 in G1 phase. Biochem J.
326:61–68. 1997.
|
|
4
|
Kreiner T and Moore HP: Membrane traffic
between secretory compartments is differentially affected during
mitosis. Cell Regul. 1:415–424. 1990.PubMed/NCBI
|
|
5
|
Berlin RD, Oliver JM and Walter RJ:
Surface functions during mitosis I: phagocytosis, pinocytosis and
mobility of surface-bound Con A. Cell. 15:327–341. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Berlin RD and Oliver JM: Surface functions
during mitosis. II Quantitation of pinocytosis and kinetic
characterization of the mitotic cycle with a new fluorescence
technique. J Cell Biol. 85:660–671. 1980. View Article : Google Scholar
|
|
7
|
Sager PR, Brown PA and Berlin RD: Analysis
of transferrin recycling in mitotic and interphase HeLa cells by
quantitative fluorescence microscopy. Cell. 39:275–282. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Warren G, Featherstone C, Griffiths G and
Burke B: Newly synthesized G protein of vesicular stomatitis virus
is not transported to the cell surface during mitosis. J Cell Biol.
97:1623–1628. 1983. View Article : Google Scholar
|
|
9
|
Kiyokawa N, Lee EK, Karunagaran D, Lin SY
and Hung MC: Mitosis-specific negative regulation of epidermal
growth factor receptor, triggered by a decrease in ligand binding
and dimerization, can be overcome by overexpression of receptor. J
Biol Chem. 272:18656–18665. 1997. View Article : Google Scholar
|
|
10
|
Gomez-Cambronero J: p42-MAP kinase is
activated in EGF-stimulated interphase but not in
metaphase-arrested HeLa cells. FEBS Lett. 443:126–130. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Klein S, Kaszkin M, Barth H and Kinzel V:
Signal transduction through epidermal growth factor receptor is
altered in HeLa monolayer cells during mitosis. Biochem J.
322:937–946. 1997.PubMed/NCBI
|
|
12
|
Newberry EP and Pike LJ:
Cell-cycle-dependent modulation of EGF-receptor-mediated signaling.
Biochem Biophys Res Commun. 208:253–259. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Choi C and Helfman DM: The Ras-ERK pathway
modulates cytoskeleton organization, cell motility and lung
metastasis signature genes in MDA-MB-231 LM2. Oncogene. Sep
2–2013.(Epub ahead of print).
|
|
14
|
Cha DS, Datla US, Hollis SE, Kimble J and
Lee MH: The Ras-ERK MAPK regulatory network controls
dedifferentiation in Caenorhabditis elegans germline.
Biochim Biophys Acta. 1823:1847–1855. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yoon S and Seger R: The extracellular
signal-regulated kinase: multiple substrates regulate diverse
cellular functions. Growth Factors. 24:21–44. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hayne C, Xiang X and Luo Z: MEK inhibition
and phosphorylation of serine 4 on B23 are two coincident events in
mitosis. Biochem Biophys Res Commun. 321:675–680. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Laird AD, Morrison DK and Shalloway D:
Characterization of Raf-1 activation in mitosis. J Biol Chem.
274:4430–4439. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ziogas A, Lorenz IC, Moelling K and
Radziwill G: Mitotic Raf-1 is stimulated independently of Ras and
is active in the cytoplasm. J Biol Chem. 273:24108–24114. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dangi S and Shapiro P: Cdc2-mediated
inhibition of epidermal growth factor activation of the
extracellular signal-regulated kinase pathway during mitosis. J
Biol Chem. 280:24524–24531. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu L, Shi H, Chen X and Wang Z:
Regulation of EGF-stimulated EGF receptor endocytosis during M
phase. Traffic. 12:201–217. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Margadant C, Cremers L, Sonnenberg A and
Boonstra J: MAPK uncouples cell cycle progression from cell
spreading and cytoskeletal organization in cycling cells. Cell Mol
Life Sci. 70:293–307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shi H and Shen L: The alteration of
extracellular signal-regulated kinase (ERK) activity of COS7 cells
from interphase to mitosis. Cell Mol Biol (Noisy-le-grand).
56(Suppl): OL1427–OL1433. 2010.PubMed/NCBI
|
|
23
|
Anderson D, Koch CA, Grey L, Ellis C,
Moran MF and Pawson T: Binding of SH2 domains of phospholipase C
gamma 1, GAP, and Src to activated growth factor receptors.
Science. 250:979–982. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Moran MF, Koch CA, Anderson D, et al: Src
homology region 2 domains direct protein-protein interactions in
signal transduction. Proc Natl Acad Sci USA. 87:8622–8626. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Koch CA, Anderson D, Moran MF, Ellis C and
Pawson T: SH2 and SH3 domains: elements that control interactions
of cytoplasmic signaling proteins. Science. 252:668–674. 1991.
View Article : Google Scholar
|
|
26
|
Pawson T: Protein modules and signalling
networks. Nature. 373:573–580. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao Y, Thomas HD, Batey MA, et al:
Preclinical evaluation of a potent novel DNA-dependent protein
kinase inhibitor NU7441. Cancer Res. 66:5354–5362. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ma DM, Ji YJ, Yang F, Liu W, Wan Z and Li
RY: Effects of U0126 on growth and activation of mitogen-activated
protein kinases in Aspergillus fumigatus. Chin Med J (Engl).
126:220–225. 2013.PubMed/NCBI
|
|
29
|
Newton R, Cambridge L, Hart LA, Stevens
DA, Lindsay MA and Barnes PJ: The MAP kinase inhibitors, PD098059,
UO126 and SB203580, inhibit IL-1beta-dependent PGE(2) release via
mechanistically distinct processes. Br J Pharmacol. 130:1353–1361.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nam HJ, Kim S, Lee MW, et al: The ERK-RSK1
activation by growth factors at G2 phase delays cell cycle
progression and reduces mitotic aberrations. Cell Signal.
20:1349–1358. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rao VN and Reddy ES: elk-1 proteins
interact with MAP kinases. Oncogene. 9:1855–1860. 1994.PubMed/NCBI
|
